Garheng Kong is Director of Strongbridge Biopharma plc. Currently has a direct ownership of 0 shares of SBBP, which is worth approximately $0. The most recent transaction as insider was on Oct 05, 2021, when has been sold 63,993 shares (Ordinary Shares) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Garheng Kong Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 05 2021
SELL
Sale (or disposition) back to the issuer
-
63,993 Reduced 100.0%
0 Ordinary Shares
Oct 01 2021
SELL
Payment of exercise price or tax liability
$36,592 $2.06 p/Share
17,763 Reduced 21.73%
63,993 Ordinary Shares
May 18 2021
BUY
Grant, award, or other acquisition
-
40,000 Added 32.85%
81,756 Ordinary Shares
May 14 2021
SELL
Payment of exercise price or tax liability
$45,120 $2.35 p/Share
19,200 Reduced 31.5%
41,756 Ordinary Shares

Also insider at

LH
LABORATORY CORP OF AMERICA HOLDINGS Healthcare
VERO
Venus Concept Inc. Healthcare
XERS
Xeris Biopharma Holdings, Inc. Healthcare
ALIM
ALIMERA SCIENCES INC Healthcare
GK

Garheng Kong

Director
Burlington, NC

Track Institutional and Insider Activities on SBBP

Follow Strongbridge Biopharma plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBBP shares.

Notify only if

Insider Trading

Get notified when an Strongbridge Biopharma PLC insider buys or sells SBBP shares.

Notify only if

News

Receive news related to Strongbridge Biopharma plc

Track Activities on SBBP